Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)

INTRODUCTION AND OBJECTIVES: Cardiovascular disease (CVD) is the leading cause of mortality worldwide and increased levels of low-density lipoprotein cholesterol (LDL-C) are an important modifiable risk factor. Statins lower LDL-C levels and have been shown to reduce CVD risk. Despite the widespread...

Descripción completa

Detalles Bibliográficos
Autores principales: Raal, Frederick J, Blom, Dirk J, Naidoo, Shanil, Bramlage, Peter, Brudi, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2013
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821092/
https://www.ncbi.nlm.nih.gov/pubmed/24240385
http://dx.doi.org/10.5830/CVJA-2013-071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821092/
https://www.ncbi.nlm.nih.gov/pubmed/24240385
http://dx.doi.org/10.5830/CVJA-2013-071

Ejemplares similares